Atopic Dermatitis

Nursing Clinics of North America

Volumn 42, Issue 3, 2007, Pages 407-419

  Tofte, Susan ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT;

ATOPIC DERMATITIS; HUMAN; NURSING; PATIENT EDUCATION; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; SKIN CARE;

ANTI-ALLERGIC AGENTS; DERMATITIS, ATOPIC; HUMANS; PATIENT EDUCATION; PRACTICE GUIDELINES; QUALITY OF LIFE; SKIN CARE;

EID: 34548295909     PISSN: 00296465     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnur.2007.06.002     Document Type: Review

References (20)

1. Simpson E.L., and Hanifin J.M. Atopic dermatitis. J Am Acad Dermatol 53 1 (2005) 115-128
2. Laughter D., Istavan J., Tofte S., et al. The prevalence of atopic dermatitis in Oregon school children. J Am Acad Dermatol 43 (2000) 649-655
3. Kay J., Gawkrodger D.J., Mortimer M.J., et al. . The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol 30 (1994) 35-39
4. Hanifin J.M., and Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 92 Suppl (1980) 44-47
5. Eichenfield L.F., Hanifin J.M., Luger T.A., et al. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol 49 6 (2003) 1088-1095
6. Hudson T.J. Skin barrier function and allergic risk. Nat Genet 38 4 (2006) 399-400
7. Palmer C.A.N., Irvine A.D., Terron-Kwiatkowski A.T., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38 4 (2006) 441-446
8. Hanifin J.M. Atopic dermatitis. In: Moschella S.L., and Hurley H.J. (Eds). Dermatology. 3rd edition (1992), W.B. Saunders Company, Philadelphia 441-464
9. Irvine A.D., and McLean W.H.I. Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. J Invest Dermatol 126 (2006) 1200-1202
10. Chaman C.R., Morris A.D., and Williams H.C. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 142 5 (2000) 931-936
11. Hanifin J.M., Cooper K.D., Ho V.C., et al. Guidelines of care for atopic dermatitis, developed in accordance with the American academy of dermatology (AAD/American Academy of Dermatology Association "Administrative Regulations for Evidence based Clinical Practice Guidelines.". J Am Acad Dermatol 50 3 (2004) 391-404
12. Sowden J.M., Berth-Jones J., Ross J.S., et al. Double-blind, controlled crossover study of cyclosporine in adults with severe refractory atopic dermatitis. Lancet 338 (1991) 137-140
13. Meggitt S.J., Gray J.C., and Reynolds N.J. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomized controlled trial. Lancet 367 9513 (2006) 839-846
14. Hanifin J.M., Schneider L.C., Leung D.Y.M., et al. Recombinant interferon-gamma therapy for atopic dermatitis. J Am Acad Dermatol 28 (1993) 189-197
15. Takiguchi R.H., Tofte S.J., Simpson B.M., et al. Efalizumab for severe atopic dermatitis-a pilot study in adults. J Am Acad Dermatol 56 2 (2007) 222-227
16. Moran G.J., Krishnadasan A., Gorwitz R.J., et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355 (2006) 666-674
17. Sampson H.A., and Albergo R. Comparison of results of skin tests, RAST, and double-blind placebo-controlled food challenges in atopic dermatitis. J Allergy Clin Immunol 74 (1984) 26-33
18. Rowlands D., Tofte S.J., and Hanifin J.M. Does food allergy cause atopic dermatitis? Food challenge testing to dissociate eczematous from immediate reactions. Dermatol Ther 19 2 (2006) 97-103
19. Chamlin S.L., Frieden I.J., Williams M.L., et al. Effects of atopic dermatitis on young American children and their families. Pediatrics 114 3 (2004) 607-611
20. Lapidus C.S., Schwarz D.F., and Honig P.J. Atopic dermatitis in children: who cares? Who pays?. J Am Acad Dermatol 28 (1993) 699-703